Provided by Tiger Fintech (Singapore) Pte. Ltd.

LakeShore Biopharma Co., Ltd.

2.00
+0.10005.26%
Post-market: 2.000.00000.00%17:04 EDT
Volume:6.87K
Turnover:13.38K
Market Cap:38.16M
PE:-0.36
High:2.13
Open:1.90
Low:1.90
Close:1.90
Loading ...

Company Profile

Company Name:
LakeShore Biopharma Co., Ltd.
Exchange:
NASDAQ
Establishment Date:
2002
Employees:
758
Office Location:
Building No. 2,38 Yongda Road,Daxing Biomedical Industry Park,Daxing District,Beijing,China
Zip Code:
102629
Fax:
- -
Introduction:
YS Biopharma Co., Ltd., a biopharmaceutical company, engages in discovering, developing, manufacturing, and commercializing of vaccines and therapeutic biologics for infectious diseases and cancer. The company develops a proprietary PIKA immunomodulating technology platform and a series of product targeting PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, and PIKA YS-ON-001. It operates in China, the United States, Singapore, the United Arab Emirates, and the Philippines. The company was founded in 2002 and is based in Beijing, China.

Directors

Name
Position
Hui Shao
Director, President and Chief Business Officer, Vice Chairman of the Board
Xu Wang
Chief Executive Officer,Director
Dave Chenn
Director, Chairperson
Rachel Yu
Director and Chief Financial Officer
Adam Zhao
Director
Chunyang Shao
Director
Thomas Xue
Director

Shareholders

Name
Position
Xu Wang
Chief Executive Officer,Director
Rachel Yu
Director and Chief Financial Officer
Gang Li
Head of Marketing and Sales
Honggang Teng
Head of Production and Quality Management
Hui Shao
Director, President and Chief Business Officer, Vice Chairman of the Board
Yuan Liu
Head of Vaccine Research
Zenaida Reynoso Mojares
Chief Medical Officer